Management of an Alveolar paratesticular Rhabdomyosarcoma: A case report

Zenab Alami 1, 2, *, Amina Bouziane 1, 2, Wissal Hassani 1, 2, Fatima Zahrae Farhane 1, 2 and Touria Bouhafa 1, 2

1 Faculty of Medecine and pharmacy of FES, Sidi Mohammed Ben-Abdellah University, MOROCCO.
2 Radiatherapy Department, Oncology hospital, Hassan II University Hospital, FES, MOROCCO.
 
Case Study
World Journal of Advanced Research and Reviews, 2021, 12(02), 598–602
Article DOI: 10.30574/wjarr.2021.12.2.0602
 
Publication history: 
Received on 10 October 2021; revised on 21 November 2021; accepted on 23 November 2021
 
Abstract: 
Paratesticular Rhabdomyosarcoma is a rare mesenchymal tumor. The Alveolar variant is the one with the worse prognosis. It comprehend 20% of cases.
The treatment is multimodal combining surgery, chemotherapy and radiotherapy. Depending on the extent of disease and the staging group, the approach of treatment is different.
Here we report the case of an alveolar Paratesticular rhabdomyosarcoma and review the literature regarding this unusual clinical entity.
 
Keywords: 
Rhabdomyosarcome; Paratesticular; Staging; Surgery; Radiotherapy
 
Full text article in PDF: 
Share this